Abstract
Chronic inflammation appears to play a critical role in sickness behavior caused by diabetes mellitus. Astaxanthin has been used in treating diabetes mellitus and diabetic complications because of its neuroprotective and anti-inflammatory actions. However, whether astaxanthin can improve sickness behavior induced by diabetes and its potential mechanisms are still unknown. The aim of this study was to investigate the effects of astaxanthin on diabetes-elicited abnormal behavior in mice and its corresponding mechanisms. An experimental diabetic model was induced by streptozotocin (150 mg/kg) and astaxanthin (25 mg/kg/day) was provided orally for 10 weeks. Body weight and water consumption were measured, and the sickness behavior was evaluated by the open field test (OFT) and closed field test (CFT). The expression of glial fibrillary acidic protein (GFAP) was measured, and the frontal cortical cleaved caspase-3 positive cells, interleukin-6 (IL-6), and interleukin-1β (IL-1β) expression levels were also investigated. Furthermore, cystathionine β-synthase (CBS) in the frontal cortex was detected to determine whether the protective effect of astaxanthin on sickness behavior in diabetic mice is closely related to CBS. As expected, we observed that astaxanthin improved general symptoms and significantly increase horizontal distance and the number of crossings in the OFT and CFT. Furthermore, data showed that astaxanthin could decrease GFAP-positive cells in the brain and down-regulate the cleaved caspase-3, IL-6, and IL-1β, and up-regulate CBS in the frontal cortex. These results suggest that astaxanthin provides neuroprotection against diabetes-induced sickness behavior through inhibiting inflammation, and the protective effects may involve CBS expression in the brain.
Similar content being viewed by others
References
Aksu I, Ates M, Baykara B et al (2012) Anxiety correlates to decreased blood and prefrontal cortex IGF-1 levels in streptozotocin induced diabetes. Neurosci Lett 531:176–181
Ambati RR, Phang SM, Ravi S et al (2014) Astaxanthin: sources, extraction, stability, biological activities and its commercial applications a review. Mar Drugs 12:128–152
Aminzadeh MA, Vaziri ND (2012) Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease. Nephrol Dial Transplant 27:498–504
Bae SK, Heo CH, Choi DJ et al (2013) A ratiometric two-photon fluorescent probe reveals reduction in mitochondrial H2S production in Parkinson’s disease gene knockout astrocytes. J Am Chem Soc 135:9915–9923
Chen ML, Chen CH (2007) Chronic antipsychotics treatment regulates MAOA, MAOB and COMT gene expression in rat frontal cortex. J Psychiatr Res 41:57–62
Chen C, Wang Y, Zhang J et al (2014) Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice. Dis Model Mech 7:723–730
Choi K, Le T, McGuire J et al (2012) Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear. J Psychiatr Res 46:882–889
Chourbaji S, Urani A, Inta I et al (2006) IL-6 knock out mice exhibit resistance to stress-induced development of depression like behaviors. Neurobiol Dis 23:587–594
Damián JP, Acosta V, Da Cuña M et al (2014) Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests. Exp Anim 63:277–287
Dong LY, Jin J, Lu G et al (2013) Astaxanthin attenuates the apoptosis of retinal ganglion cells in db/db mice by inhibition of oxidative stress. Mar Drug 11:960–974
El-Akabawy G, El-Kholy W (2014) Neuroprotective effect of ginger in the brain of streptozotocin-induced diabetic rats. Ann Anat 196:119–128
Enhamre-Brolin E, Carlsson A, Hallberg M et al (2013) Growth hormone reverses streptozotocin-induced cognitive impairments in male mice. Behav Brain Res 238:273–278
Fu YY, Zhang F, Zhang L et al (2014) Mangiferin regulates interleukin-6 and cystathionine-b-synthase in lipopolysaccharide-induced brain injury. Cell Mol Neurobiol 34:651–657
Gibney SM, McGuinness B, Prendergast C et al (2013) Poly I:C-inducedactivation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression. Brain Behav Immun 28:170–181
Giuliani D, Ottani A, Zaffe D et al (2013) Hydrogen sulfide slows down progression of experimental Alzheimer’s disease by targeting multiple pathophysiological mechanisms. Neurobiol Learn Mem 104:82–91
Gong QH, Shi XR, Hong ZY et al (2011) A new hope for neurodegeneration: possible role of hydrogen sulfide. J Alzheimers Dis 24:173–182
Harden LM, du Plessis I, Roth J et al (2011) Differences in the relative involvement of peripherally released interleukin (IL)-6, brain IL-1β and prostanoids inmediating lipopolysaccharide-induced fever and sickness behavior. Psychoneuroendocrinology 36:608–622
Holmes C, Cunningham C, Zotova E et al (2011) Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology 77:212–218
Ishigami M, Hiraki K, Umemura K et al (2009) A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid Redox Signal 11:205–214
Ishiki M, Nishida Y, Ishibashi H et al (2013) Impact of divergent effects of astaxanthin on insulin signaling in L6 cells. Endocrinology 154:2600–2612
Jing YH, Chen KH, Kuo PC et al (2013) Neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatment with resveratrol. Neuroendocrinology 98:116–127
Katon W (2010) Depression and diabetes: unhealthy bedfellows. Depress Anxiety 27:323–326
Katon WJ, Young BA, Russo J et al (2013) Associat-ion of depression with increased risk of severe hypoglycemic episodes in patients with diabetes. Ann Fam Med 11:245–250
Keleshian VL, Modi HR, Rapoport SI et al (2013) Aging is associated with altered inflammatory, arachidonic acid cascade, and synaptic markers, influenced by epigenetic modifications, in the human frontal cortex. J Neurochem 125:63–73
Kidd P (2011) Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern Med Rev 16:355–364
Kim YJ, Kim YA, Yokozawa T (2009) Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin. J Aqric Food Chem 57:8793–8797
Kimura Y, Dargusch R, Schubert D (2006) Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid Redox Signal 8:661–670
Kleinridders A, Ferris HA, Cai W et al (2014) Insulin action in brain regulates systemic metabolism and brain function. Diabetes 63:2232–2243
Lindahl B (2008) An illness behavior view on coping with diabetes. Int J Behav Med 15:165–166
Liu YW, Zhu X, Yang QQ et al (2013) Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats. Psychopharmacology 228:585–594
Liu YW, Zhu X, Zhang L et al (2014) Cerebroprotective effects of ibuprofen on diabetic encephalopathy in rats. Pharmacol Biochem Behav 117:128–136
Lu YP, Liu SY, Sun H et al (2010) Neuroprotective effect of astaxanthin on H(2)O(2)-induced neurotoxicity in vitro and on focal cerebral ischemia in vivo. Brain Res 1360:40–48
Marin DP, Bolin AP, Macedo Rde C et al (2011) ROS production in neutrophils from alloxan-induced diabetic rats treated in vivo with astaxanthin. Int Immunopharmacol 11:103–109
Marrero D, Pan Q, Barrett-Connor E et al (2014) Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study. Qual Life Res 23:75–88
Meng XF, Wang XL, Tian XJ et al (2014) Nod-like receptor protein 1 inflammasome mediates neuron injury under high glucose. Mol Neurobiol 49:673–684
O’Connor JC, Satpathy A, Hartman ME et al (2005) IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes. J Immunol 174:4991–4997
Ola MS, Aleisa AM, Al-Rejaie SS et al (2014) Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats. Neurol Sci 35:1003–1008
Patel SS, Udayabanu M (2014) Urtica dioica extract attenuates depressive like behavior and associative memory dysfunction in dexamethasone induced diabetic mice. Metab Brain Dis 29:121–130
Petrak F, Herpertz S, Stridde E et al (2013) Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin. Diabetes Technol Ther 15:703–711
Qu K, Lee SW, Bian JS et al (2008) Hydrogen sulfide: neurochemistry and neurobiology. Neurochem Int 52:155–165
Rajashree R, Kholkute SD, Goudar SS (2011) Effects of duration of diabetes on behavioural and cognitive parameters in streptozotocin-induced juvenilediabetic rats. Malays J Med Sci 18:26–31
Renner NA, Sansing HA, Inglis FM et al (2013) Transient acidification and subsequent proinflammatory cytokine stimulation of astrocytes induce distinct activation phenotypes. J Cell Physiol 228:1284–1294
Ridderinkhof KR, Ullsperger M, Crone EA et al (2004) The role of the medial frontal cortex in cognitive control. Science 306:443–447
Saavedra JM (2012) Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders. Cell Mol Neurobiol 32:667–681
Sajatovic M, Dawson NV, Perzynski AT et al (2011) Best practices: optimizing care for people with serious mental illness and comorbid diabetes. Psychiatr Serv 62:1001–1003
Sharma AN, Elased KM, Garrett TL et al (2010) Neurobehavioral deficits in db/db diabetic mice. Physiol Behav 101:381–388
Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M et al (2011) Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 16:751–762
Silverman MN, Mukhopadhyay P, Belyavskaya E et al (2013) Glucocorticoid receptor dimerization is required for proper recovery of LPS-induced inflammation, sickness behavior and metabolism in mice. Mol Psychiatry 18:1006–1017
Sima AA (2010) Encephalopathies: the emerging diabetic complications. Acta Diabetol 47:279–293
Sima AA, Zhang W, Kreipke CW et al (2009) Inflammation in diabetic encephalopathy is prevented by C-peptide. Rev Diabet Stud 6:37–42
Singh S, Padovani D, Leslie RA et al (2009) Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions. J Biol Chem 284:22457–22466
Speranza L, Pesce M, Patruno A et al (2012) Astaxanthin treatment reduced oxidative induced pro-inflammatory cytokines secretion in U937: SHP-1 as a novel biological target. Mar Drug 10:890–899
Spulber S, Edoff K, Hong L et al (2012) Molecular hydrogen reduces LPS-induced neuroinflammation and promotes recovery from sickness behaviour in mice. PLoS ONE 7:e42078
Takao K, Kobayashi K, Hagihara H et al (2013) Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain andconfers molecular, neuronal, and behavioral phenotypes related to schizophrenia. Neuropsychopharmacology 38:1409–1425
Talaei F, Van Praag VM, Shishavan MH et al (2014) Increased protein aggregation in Zucker diabetic fatty rat brain: identification of key mechanistic targets and the therapeutic application of hydrogen sulfide. BMC Cell Biol 15:1–16
Tezuka T, Tamura M, Kondo MA et al (2013) Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis. Neurobiol Dis 59:63–68
Tomassoni D, Nwankwo IE, Gabrielli MG et al (2013) Astrogliosis in the brain of obese Zucker rat: a model of metabolic syndrome. Neurosci Lett 543:136–141
Tripathi DN, Jena GB (2008) Astaxanthin inhibits cytotoxic and genotoxic effects of cyclophosphamide in mice germ cells. Toxicology 248:96–103
Wang HN, Wang L, Zhang RG et al (2014) Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoidsystem. J Psychiatr Res 51:79–87
Wiliński B, Wiliński J, Somogyi E et al (2013) Metformin raises hydrogen sulfide tissue concentrations in various mouse organs. Pharmacol Rep 65:737–742
Wu TH, Lin CH (2008) IL-6 mediated alterations on immobile behavior of rats in the forced swim test via ERK1/2 activation in specific brain regions. Behav Brain Res 193:183–191
Yuan JP, Peng J, Yin K et al (2011) Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae. Mol Nutr Food Res 55:150–165
Zhang X, Bian JS (2014) Hydrogen sulfide: a neuromodulator and neuroprotectant in the central central nervous system. ACS Chem Neurosci 5:876–883
Zhang M, Shan H, Wang Y et al (2013a) The expression changes of cystathionine-β-synthase in brain cortex after traumatic brain injury. J Mol Neurosci 51:57–67
Zhang M, Shan H, Wang T et al (2013b) Dynamic change of hydrogen sulfide after traumatic brain injury and its effect in mice. Neurochem Res 38:714–725
Zhang Q, Yuan L, Liu D et al (2014) Hydrogen sulfide attenuates hypoxia-induced neurotoxicity through inhibiting microglial activation. Pharmacol Res 84:32–44
Acknowledgments
This work was supported by the National Natural Science Foundation of China (81371300), the Education Departmental Natural Science Research Funds of Jiangsu Provincial Higher School of China (13KJB310021, 13KJD310003), the Project of Xuzhou science and technology plan (KC14SH076), the Foundation of President of Xuzhou Medical College (2012KJZ06), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the Qing Lan Project of Jiangsu Province. Thanks to Hongyan Dong, Hongli Yu, Meng Wang, Baole Zhang and Xuebin Qu for their support and help during the experiments.
Conflict of interest
All authors state that they have no conflict of interest in the present study.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Chang-jiang Ying, Fang Zhang, Xiao-yan Zhou have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Ying, Cj., Zhang, F., Zhou, Xy. et al. Anti-inflammatory Effect of Astaxanthin on the Sickness Behavior Induced by Diabetes Mellitus. Cell Mol Neurobiol 35, 1027–1037 (2015). https://doi.org/10.1007/s10571-015-0197-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-015-0197-3